Cala Trio™; The first non-invasive personalized therapy for hand tremors

Translate to Spanish or other 102 languages!

Source information: https://calatrio.com 

Mega Doctor News

- Advertisement -

The first targeted, wearable therapy designed to treat essential tremor (ET). The therapy delivers meaningful results for most patients after just a single session. Cala Trio™ requires a prescription from a medical doctor.

Source information: https://calatrio.com 

The Science

Surface stimulation delivered at your wrist is thought to disrupt the central tremor network in your brain that causes the hand tremor.

- Advertisement -
  • Developed through Clinical Studies
  • 64% of patients reported having persistent relief for an average of 94 minutes
  • 54% of patient’s tremor power improved by at least 50%

See if it’s right for you

A new approach to managing essential tremor

Non-invasive

Source information: https://calatrio.com 

Cala Trio™ is a wrist worn wearable therapy. No surgery or invasive procedures needed.

Drug Free

Source information: https://calatrio.com 

Tremor reduction without systemic side effects and drug interactions. A new individualized solution for essential tremor that fits with the flow of your life.

Easy to Try

Source information: https://calatrio.com 

There is no perfect treatment for everyone. If Cala Trio™ is not right for you, simply return within 60 days for a full refund less the $99 trial fee.

- Advertisement -

Results

The image below is an actual patient test (Archimedes Spiral Task) before and after a 40-minute stimulation therapy with Cala Trio.

Indications for Use

Cala Trio is indicated to aid in the transient relief of hand tremors in the treated hand following stimulation in adults with essential tremor. Please refer to the Safety Information for a complete listing of warnings and cautions.

Caution: Federal law restricts this device to sale by or on the order of a physician.

Visit https://calatrio.com for more information. All information is sourced from this site. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Heart Earns National Recognition for Exceptional Stroke Care

Despite significant advances in prevention and treatment, cardiovascular disease remains the leading cause of death in the United States, accounting for nearly three in 10 deaths nationwide and claiming more than 940,000 lives each year, according to the Centers for Disease Control and Prevention (CDC).

Why Older Men Should Reconsider Their Long-Term Medications

One in three men will experience moderate-to-severe lower urinary tract symptoms in their lifetime, with symptoms including frequent urination, difficulty starting urination, nocturia and a weak urine stream. Although these are common symptoms, in older men, they can significantly impact quality of life.

STHS McAllen Recognized as National Leader in Stroke Care with 7th Consecutive Gold Plus Award

Stroke is the fifth-leading cause of death in the United States and one of the leading causes of serious long-term disability nationwide, according to the Stroke Awareness Foundation, affecting nearly 800,000 Americans each year.

Medicare’s New $50 GLP-1 Coverage: 7 Essential Facts to Know

For decades, it’s been against the law for Medicare to pay for weight-loss medication, but that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other reasons, access to some weight management medications if they meet certain weight and health criteria.
- Advertisement -